The Patent Finder
US

Compositions and Methods for Modulating Hepatocyte Nuclear Factor 4-Alpha (HNF4alpha) Gene Expression

US 11,987,791 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Omga Liquidating, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Nov 24, 2041 · High confidence

Filed Sep 23, 2020 as application 17/029,820 · Granted May 21, 2024
Base term plus 427 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2020 2041
Clock starts
Sep 23, 2020
Term ends
Nov 24, 2041
Granted
May 21, 2024
base term patent term adjustment Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
427
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 427 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 23, 2020, when this application, 17/029,820, was filedSep 23, 2040High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+427 days, USPTO patent term adjustment recordNov 24, 2041High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 24, 2041High confidence

This family

US 11,987,791this patent
Nov 2041
Nov 2041
Application 18/637,630Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 3, 2021
Reel 56117, frame 406
Smith, Jesse Jerome; Kennedy, Jodi Michelle; Farelli, Jeremiah D.; Goss, Kendrick Alan; Scheidegger, Adam Walter; Rao, Timsi; Cobaugh, Christian Wessel; Kassa, YosephOmega Therapeutics, Inc.Assignment of Assignor's Interest
Feb 10, 2025
Reel 70167, frame 243
Omega Therapeutics, Inc.Pioneering Medicines 08- B, Inc.Security Interest
Feb 23, 2026
Reel 73860, frame 886
Omga Liquidating, Inc. (F/K/A Omega Therapeutics, Inc.)Flagship Labs 114, Inc.Assignment of Assignor's Interest
Apr 13, 2026
Reel 75384, frame 788
Omega Therapeutics, Inc.Omga Liquidating, Inc.Change of Name
Apr 13, 2026
Reel 75384, frame 845
Flagship Labs 114, Inc.Sepia Therapeutics, Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited